´ëÇѺñ´¢ÀÇÇÐȸ È£³²Áöȸ Çмú´ëȸ : 2022-06-18±³À°ÀÏÀÚ : 2022-06-18
±³À°Àå¼Ò : Ȧ¸®µ¥ÀÌ ÀÎ ±¤ÁÖ È£ÅÚ 3Ãþ ÄÁº¥¼ÇȦ1
±³À°ÁÖÁ¦ :
´ëÇѺñ´¢ÀÇÇÐȸ È£³²Áöȸ Çмú´ëȸÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : È£³²Áöȸ
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190
À̸ÞÀÏ :
urology@urology.or.kr ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
±¤ÁÖ±¤¿ª½Ã±³À°½Ã°£ : 2 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í 1. ¼±Âø¼ø 50ÀÎ ÀÌÇÏ Á¢¼ö(»çÀüµî·Ï¸¸ °¡´É) 2. ÇöÀåµî·Ï ¾øÀ½
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-18 Ȧ¸®µ¥ÀÌ ÀÎ ±¤ÁÖÈ£ÅÚ, 3Ãþ ÄÁº¥¼ÇȦ1 14:30~14:50 Anticholinergic burden Á¶¿øÁø(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 06-18 Ȧ¸®µ¥ÀÌ ÀÎ ±¤ÁÖÈ£ÅÚ, 3Ãþ ÄÁº¥¼ÇȦ1 14:50~15:10 Management of nocturia and nocturnal polyuria. À¯µ¿ÈÆ(±¤Áֱ⵶º´¿ø)
±³À°½Ã°£ 06-18 Ȧ¸®µ¥ÀÌ ÀÎ ±¤ÁÖÈ£ÅÚ, 3Ãþ ÄÁº¥¼ÇȦ1 15:10~15:30 Current management of undescended testis ±è¼±¿Á(Àü³²ÀÇ´ë)
±³À°½Ã°£ 06-18 Ȧ¸®µ¥ÀÌ ÀÎ ±¤ÁÖÈ£ÅÚ, 3Ãþ ÄÁº¥¼ÇȦ1 15:30~16:00 COVID-19: Special considerations in urological conditions ±èÅÂÇü(Áß¾ÓÀÇ´ë)
ÈÞ½Ä 06-18 Ȧ¸®µ¥ÀÌ ÀÎ ±¤ÁÖÈ£ÅÚ, 3Ãþ ÄÁº¥¼ÇȦ1 16:00~16:20 Coffee break ¹× »çÁø ÃÔ¿µ ()
±³À°½Ã°£ 06-18 Ȧ¸®µ¥ÀÌ ÀÎ ±¤ÁÖÈ£ÅÚ, 3Ãþ ÄÁº¥¼ÇȦ1 16:20~16:40 Optimal regimen for TRT in LOH Patients ½ÅÀ¯¼·(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 06-18 Ȧ¸®µ¥ÀÌ ÀÎ ±¤ÁÖÈ£ÅÚ, 3Ãþ ÄÁº¥¼ÇȦ1 16:40~17:00 Erectile dysfunction management after prostate cancer treatment Á¤È£¼®(Àü³²ÀÇ´ë)
±³À°½Ã°£ 06-18 Ȧ¸®µ¥ÀÌ ÀÎ ±¤ÁÖÈ£ÅÚ, 3Ãþ ÄÁº¥¼ÇȦ1 17:00~17:30 The current status of cytoreductive nephrectomy ÇÔ¿ø½Ä(¿¬¼¼ÀÇ´ë)
±âŸ 06-18 Ȧ¸®µ¥ÀÌ ÀÎ ±¤ÁÖÈ£ÅÚ, 3Ãþ ÄÁº¥¼ÇȦ1 17:30~17:50 Case presentation ()
±âŸ 06-18 Ȧ¸®µ¥ÀÌ ÀÎ ±¤ÁÖÈ£ÅÚ, 3Ãþ ÄÁº¥¼ÇȦ1 17:50~18:00 °øÁö ¹× ÃÑȸ ()